Pharmacists in Biscoe, NC Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Dr. Stephanie Ann Zyra, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 529 East Main Street, Biscoe, NC 27209 Phone: 910-428-2531 |
Ms. Marion Smith Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Montgomery Xing, Biscoe, NC 27209 Phone: 910-428-3313 |
Dr. Rachel Bruce, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Montgomery Xing, Biscoe, NC 27209 Phone: 910-428-3313 Fax: 910-428-4960 |
 Charles Ingram Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Montgomery Xing, Biscoe, NC 27209 Phone: 910-428-3313 Fax: 910-428-4960 |
Karen Chavis Clark, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2295 Nc Highway 24 27 E, Biscoe, NC 27209 Phone: 910-428-1150 Fax: 910-428-1155 |
Dr. Johnda Reynolds Farlow, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Montgomery Xing, Biscoe, NC 27209 Phone: 910-428-3313 Fax: 910-428-4960 |
News Archive
Bristol-Myers completes tender offer for Inhibitex
Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc. at a purchase price of $26.00 per share.
Cyclists perform better in open-ended laboratory tests, study finds
Scientists at the University of Kent's School of Sport and Exercise Sciences have discovered that cyclists can perform better when they do not have to pace their efforts.
New finding reveals that majority of Americans feel that recession is not over
An overwhelming majority of Americans appear to disagree with Fed Chairman Bernanke's statement that the recession is 'likely over' as 78% say it isn't, according to the latest American Pulse Survey of 6,976 Americans. 76% of Democrats, 84% of Republicans and 75.6% of Independents concur, making this one subject that all parties can agree upon.
Mathematical modeling helps researchers track and tackle COVID-19 pandemic
The Editor-in-Chief Vitaly Volpert of the Institut Camille Jordan, University ofLyon, France, reviews how the public's new favourite scientific discipline, mathematical modelling, is being used to track and tackle the COVID-19 pandemic.
FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
› Verified 1 days ago
Pharmacists
Dentists
Occupational Therapists
Psychologists
Clinical Social Workers